Mukka Proteins LimitedMUKKANSE
Mukka Proteins allots 2 crore preferential convertible warrants worth Rs. 47 crore
As filed · Mukka Proteins Limited has informed the Exchange regarding allotment of 20000000 securities pursuant to Preferential Issue at its circular resolution dated September 09, 2026.
CapitalMixedNotablemateriality 68 out of 100
What happened
FactMukka Proteins allotted 2,00,00,000 convertible warrants to identified non-promoter investors at an issue price of Rs. 23.50 per warrant, aggregating to Rs. 47 crore. Each warrant can be converted into one fully paid-up equity share within 18 months upon payment of the remaining 75% of the issue price; 25% was received upfront.
Why it matters
CapitSignal interpretationShares are issued to named investors at a set price, diluting existing holders and changing who sits on the register.
Watch next
Fact- Who the allottees are
- Issue price versus market price
- Lock-in period on the new shares
Evidence
How CapitSignal classified this
- Reasoning:
- The allotment provides Mukka Proteins with a preferential capital infusion while creating potential future equity dilution if the warrants are converted. The remaining 75% of the issue price is payable on conversion, which may provide additional funds within the stated 18-month period.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%